Growth Hormone (GH) Replacement Therapy in Adult-Onset GH Deficiency: Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Placebo-Controlled Trial

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 5, 2004, Pages 2048-2056

  Hoffman, Andrew R ^a,o   Kuntze, Joyce E ^b   Baptista, Joyce ^b   Baum, Howard B A ^c   Baumann, Gerhard P ^e   Biller, Beverly M K ^c   Clark, Richard V ^d   Cook, David ^f   Inzucchi, Silvio E ^g   Kleinberg, David ^h   Klibanski, Anne ^c   Phillips, Lawrence S ⁱ   Ridgway, E Chester ^j   Robbins, Richard J ^k   Schlechte, Janet ^l   Sharma, Meeta ^m   Thorner, Michael O ⁿ   Vance, Mary Lee ⁿ  

^a STANFORD UNIVERSITY   (United States)

^b GENENTECH INC   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF COLORADO   (United States)

^k MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^l UNIVERSITY OF IOWA   (United States)

^m G W Univ Sch Med Hlth Sci   (United States)

ⁿ UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^o VA PALO ALTO HEALTH CARE SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTROGEN; GLUCOSE; GROWTH HORMONE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SOMATOMEDIN C;

ADULT; AGED; ANTHROPOMETRY; ARTHRALGIA; ARTHRITIS; ARTICLE; BODY COMPOSITION; CARDIOVASCULAR RISK; CARPAL TUNNEL SYNDROME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; ENDURANCE; FEMALE; GLUCOSE METABOLISM; GRAVES DISEASE; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE STRENGTH; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADULT; AGED; ANTHROPOMETRY; BODY COMPOSITION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; MALE; METABOLISM, INBORN ERRORS; MIDDLE AGED; MUSCLE, SKELETAL; PHYSICAL ENDURANCE; PLACEBOS; QUALITY OF LIFE; RECOMBINANT PROTEINS;

EID: 2442505516     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030346     Document Type: Article

References (50)

1. Hoffman DM, O'Sullivan AJ, Freund J, Ho KKY 1995 Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. J Clin Endocrinol Metab 80:72-77
2. Bengtsson AB, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Talli J, Sjostrom L, Isaksson OG 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309-317
3. Snel YE, Brummer RJ, Doerga ME, Zelissen PM, Bakker CJ, Hendriks MJ, Koppeschaar HP 1995 Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects. Am J Clin Nutr 61:1290-1294
4. de Boer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA 1994 Serum lipid levels in growth hormone deficient men. Metabolism 43:199-203
5. Binnerts A, Deurenberg P, Swart GR, Wilson JH, Lamberts SWJ 1992 Body composition in growth hormone-deficient adults. Am J Clin Nutr 55:918-923
6. Beshyah SA, Freemanfle C, Thomas E, Rutherford O, Page B, Murphy M, Johnston DG 1995 Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clin Endocrinol (Oxf) 42: 179-189
7. Jorgensen JOL, Thusesn L, Muller J, Ovesen P, Skakkebaek NE, Christiansen JS 1994 Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. Eur J Endocrinol 130:224-228
8. Cuneo R, Salomon F, Wiles CM, Sonksen PH 1990 Skeletal muscle performance in adults with growth hormone deficiency. Horm Res 33(Suppl 4):55-60
9. Rosen T, Eden S, Larson G, Wilhelmsen L, Bengtsson B-A 1993 Cardiovascular risk factors in adult subjects with growth hormone deficiency. Acta Endocrinol 129:195-200
10. Stabler B, Turner JR, Girdler SS, Light KC, Underwood LE 1992 Reactivity to stress and psychological adjustments in adults with pituitary insufficiency. Clin Endocrinol (Oxf) 36:467-473
11. Rosen T, Wiren L, Wilhelmsen L, Wiklund I, Bengtsson B-A 1994 Decreased psychological well-being in adult subjects with growth hormone deficiency. Clin Endocrinol (Oxf) 40:111-116
12. de Boer H, Blok GJ, Voerman HJ, De Vries PMJM, van der Veen EA 1992 Body composition in adult growth hormone deficient men, assessed by anthropometry and bioimpedance analysis. J Clin Endocrinol Metab 75:833-837
13. Rosen T, Bengtsson B-A 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288
14. Bjork S, Jonsson B, Westphal O, Levin J-E 1989 Quality of life of adults with growth hormone deficiency: a controlled study. Acta Paediatr Scand 356(Suppl):55-59
15. Burman P, Broman JE, Hetta J, Wiklund I, Erfurth EM, Hagg E, Karlsson FA 1995 Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab 80:3585-3590
16. McGauley GH, Cuneo RC, Salomon F, Sonksen PH 1990 Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Horm Res 33(Suppl 4):52-54
17. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Lindstedt G, Bengtsson B-A 1997 Increased fracture frequency in adult subjects with hypopituitarism and GH deficiency. Eur J Endocrinol 137:240-245
18. Vahl N, Juul A, Jørgensen JOL, Ørskov, Skakkebæk NE, Christiansen JS 2000 Continuation of growth hormone (GH) replacement in GH-deficient subjects during transition from childhood to adulthood: a two-year placebo-controlled study. J Clin Endocrinol Metab 85:1874-1881
19. Salomon F, Cuneo RC, Hesp R, Sonksen PH 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803
20. Baum HBA, Biller BMK, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A 1996 Effects of physiologic growth hormone therapy on bone density and body composition in subjects with adult-onset growth hormone deficiency. Ann Intern Med 125: 883-890
21. Johannsson G, Rosen T, Bosaeus I, Sjostrom L, Bengtsson B-A 1996 Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary subjects with adult-onset GH deficiency. J Clin Endocrinol Metab 81:2865-2873
22. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J 1961 An inventory for measuring depression. Arch Gen Psychiatry 4:561-571
23. Hunt SM, McKenna SP, McEwen J, Williams J, Papp E 1981 The Nottingham health profile: subjective health status and medical consultations. Soc Sci Med 15A:221-229
24. Fazio AF 1977 A concurrent validation study of the NCHS General Well-Being Scale. Vital Health Stat 2:73
25. Sallis JF, Haskell WL, Wood PD, Fortmann SP, Rogers T, Blair SN, Paffenbarger Jr RS 1985 Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 121:91-106
26. Reitan RM 1992 Trail-making test: manual for administration and scoring. Tucson, AZ: Reitan Neuropsychology Laboratory
27. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K, Skakkebaek NE 1994 Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78:744-752
28. Frontera WR, Hughes VA, Lutz KJ, Evans WJ 1991 A cross-sectional study of muscle strength and mass in 45- to 78-year-old men and women. J Appl Physiol 71:644-650
29. American Association of Clinical Endocrinologists 2003 Medical guidelines for clinical practice for growth hormone use in adults and children-2003 update. Endocr Pract 9:64-76
30. Cook DM, Ludlam WH, Cook MB 1999 Route of estrogen administration helps to determined growth hormone (GH) replacement dose in GH-deficient adults. J Clin Endocrinol Metab 84:3056-3960
31. Veldhuis JD 1998 Neuroendocrine control of pulsatile growth hormone release in the human relationship with gender. Growth Horm IGF Res 8(Suppl B):49-59
32. Ohlsson C, Bengtsson B-A, Isaksson OGP, Andreassen TT, Slootweg MC 1998 Growth hormone and bone. Endocr Rev 19:55-79
33. Simpson H, Savine R, Sönksen P, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Cohen P, Hintz R, Ho K, Mullis P, Robinson I, Strasburger C, Tanaka T, Thorner M, GRS Council 2002 Growth hormone replacement therapy for adults: into the new millennium. Growth Horm IGF Res 12:1-33
34. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Shalet SM 1999 Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults. Clin Endocrinol 50:749-757
35. Juul A 1999 Determination of insulin-like growth factor-I in the monitoring of growth hormone treatment with respect to efficacy of treatment and side effects: should potential risks of cardiovascular disease and cancer be considered? Horm Res 51(Suppl 3):141-148
36. de Boer H, Blok GJ, Popp-Snijders C, Stuurman L, Baxter RC, van der Veen E 1996 Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. J Clin Endocrinol Metab 81:1371-1377
37. Cook DM, Biller BM, Vance ML, Hoffman AR, Phillips LS, Ford KM, Benziger DP, Illeperuma A, Blethen SL, Attie KM, Dao LN, Reimann JD, Fielder PJ 2002 The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (Nutropin depot) in GH-deficient adults. J Clin Endocrinol Metab 87:4508-4514
38. Johannsson G, Bengtsson B-A 1998 Influence of gender and gonadal steroids on responsiveness to growth hormone replacement therapy in adults with growth hormone deficiency. Growth Horm IGF Res 8:69-75
39. Span JPT, Pieters GFFM, Sweep CGJ, Hermus ARMM, Smals AGH 2000 Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. J Clin Endocrinol Metab 85:1121-1125
40. Lieberman SA, Mitchell AM, Hintz R, Marcus R, Hoffman AR 1994 The insulin-like growth factor-I generation test: resistance to growth hormone during aging and estrogen replacement therapy. Horm Metab Res 26:229-233
41. Isley WL 2002 Growth hormone therapy for adults: not ready for prime time? Ann Intern Med 137:190-196
42. Svensson J, Stibrant Sunnerhagen K, Johannsson G 2003 Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength. J Clin Endocrinol Metab 88:2061-2069
43. Gilchrist FJ, Murray RD, Shalet SM 2002 The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults. Clin Endocrinol (Oxf) 57:363-370
44. Borson-Chazot F, Serusclat A, Kalfallah Y, Ducottet X, Sassolas G, Bernard S, Labrousse F, Pastene J, Sassolas A, Roux Y, Berthezene F 1999 Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency. J Clin Endocrinol Metab 84:1329-1333
45. Pfeifer M, Verhovec R, Zizek B, Prezelj J, Poredos P, Clayton RN 1999 Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab 84:453-457
46. Janssen YJ, Hamdy NA, Frolich M, Roelfsema F 1998 Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in subjects with adult-onset GH deficiency. J Clin Endocrinol Metab 83:2143-2148
47. Gotherstrom G, Svensson J, Koranyi J, Alpsten M, Bosaeus I, Bengtsson BA, Johannsson G 2001 A prospective study of 5 years of GH replacement therapy in GH deficient adults: sustained effects on body composition, bone mass, and metabolic indices. J Clin Endocrinol Metab 86:4657-4865
48. Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J 1998 Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clin Endocrinol (Oxf) 48:561-568
49. Johansson AG, Engstrom BE, Ljunghall S, Karlsson FA, Karlsson Burman P 1999 Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. J Clin Endocrinol Metab 84:2002-2007
50. Valimaki MJ, Salmela PI, Salmi J, Viikari J, Kataja M, Turenen H, Soppi E 1999 Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults. Eur J Endocrinol 140:545-554